1. Home
  2. SUPN vs BWIN Comparison

SUPN vs BWIN Comparison

Compare SUPN & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.27

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo The Baldwin Insurance Group Inc.

BWIN

The Baldwin Insurance Group Inc.

HOLD

Current Price

$30.77

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
BWIN
Founded
2005
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
SUPN
BWIN
Price
$48.27
$30.77
Analyst Decision
Strong Buy
Buy
Analyst Count
5
7
Target Price
$61.60
$30.43
AVG Volume (30 Days)
919.1K
1.2M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,755,000.00
$1,504,884,000.00
Revenue This Year
$22.70
$36.36
Revenue Next Year
$19.14
$10.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.34
52 Week Low
$41.78
$15.88
52 Week High
$59.68
$34.79

Technical Indicators

Market Signals
Indicator
SUPN
BWIN
Relative Strength Index (RSI) 54.48 61.07
Support Level $47.58 $24.90
Resistance Level $52.33 N/A
Average True Range (ATR) 2.42 1.50
MACD 0.21 0.10
Stochastic Oscillator 54.38 65.23

Price Performance

Historical Comparison
SUPN
BWIN

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About BWIN The Baldwin Insurance Group Inc.

The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.

Share on Social Networks: